Shikha Bhushan, Yashpal Singh Raja and Surya Mishra 2022. STREPTOMYCIN AND PYRIDOMYCIN DRUG MOLECULES PROVIDE THE MOST POTENTIAL INHIBITORS AGAINST RV3871 TO CURE TUBERCULOSIS. EPRA International Journal of Research and Development (IJRD). 7, 8 (Aug. 2022), 68–77.